Global Blood Therapeutics, Inc. Financials

Market Capitalization $4.62 Billion as of Oct. 1, 2022

Valuations Metrics as of Jul. 4, 2025

Trailing PE	15.92
Forward PE	16.28
Price to Sales TTM	C$0.76
Price to Book MRQ	C$0.91
Enterprise to Revenue	0.77
Enterprise to EBITDA	31.65

Financial Reports as of Apr. 30, 2025

Financials

Fiscal Year Ends	2025-01-31
Most Recent Quarter	2025-04-30
Profit Margin	4.79%
Operating Margin	-5.76%
Return on Assets TTM	0.31%
Return on Equity TTM	5.95%

Income Statement

Revenue TTM	C$615,681,024
Revenue per Share TTM	C$19.01
Quarterly Revenue Growth	9.50%
Gross Profit TTM	C$244,394,000
EBITDA	C$15,046,000
Net Income to Common TTM	C$29,515,000
Diluted EPS TTM	C$0.91
Quarterly Earnings Growth YoY	9.46%

Balance Sheet

Total Cash MRQ	C$3,227,000
Total Cash per Share MRQ	C$0.10
Total Debt MRQ	C$
Total Debt to Equity MRQ	3.33
Current Ratio MRQ	0.93
Book Value per Share MRQ	C$15.97

Cash Flow

Operating Cash Flow TTM	C$21,609,000
Levered Free Cash Flow TTM	C$33,232,124

GBT Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	32,362,300
Float Shares	10,377,935
Avg 10 Volume	2,560
Avg 30 Volume	None
Shares Short	1,607
Short Ratio	0.97
Short % of Shares	%
% Held by Insiders	67.41%
% Held by Institutions	13.61%

Stock Price Summary

Beta	0.53
Fifty Two Week Low	C$11.18
Fifty Two Week High	C$16.84
Fifty Two Week Change	3.93%
Day 50 MA	C$12.82
Day 200 MA	C$12.87

Dividends and Splits

Forward Annual Dividend Rate	C$0.36
Forward Annual Dividend Yield	2.48%
Trailing Annual Dividend Rate	C$0.36
Trailing Annual Dividend Yield	2.48%
Payout Ratio	39.56%
Dividend Date	2025-06-27
Ex Dividend Date	2025-06-20
Last Split Factor
Last Split Date	2010-04-01